Works matching IS 17574676 AND DT 2018 AND VI 10 AND IP 6


Results: 6
    1
    2
    3

    Anti‐tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC‐dependent vulnerability.

    Published in:
    EMBO Molecular Medicine, 2018, v. 10, n. 6, p. 1, doi. 10.15252/emmm.201708289
    By:
    • Iwai, Kenichi;
    • Yaguchi, Masahiro;
    • Nishimura, Kazuho;
    • Yamamoto, Yukiko;
    • Tamura, Toshiya;
    • Nakata, Daisuke;
    • Dairiki, Ryo;
    • Kawakita, Yoichi;
    • Mizojiri, Ryo;
    • Ito, Yoshiteru;
    • Asano, Moriteru;
    • Maezaki, Hironobu;
    • Nakayama, Yusuke;
    • Kaishima, Misato;
    • Hayashi, Kozo;
    • Teratani, Mika;
    • Miyakawa, Shuichi;
    • Iwatani, Misa;
    • Miyamoto, Maki;
    • Klein, Michael G.
    Publication type:
    Article
    4
    5

    Dynamics of multiple resistance mechanisms in plasma DNA during EGFR‐targeted therapies in non‐small cell lung cancer.

    Published in:
    EMBO Molecular Medicine, 2018, v. 10, n. 6, p. 1, doi. 10.15252/emmm.201707945
    By:
    • Tsui, Dana Wai Yi;
    • Murtaza, Muhammed;
    • Wong, Alvin Seng Cheong;
    • Rueda, Oscar M.;
    • Smith, Christopher G.;
    • Chandrananda, Dineika;
    • Soo, Ross A.;
    • Lim, Hong Liang;
    • Goh, Boon Cher;
    • Caldas, Carlos;
    • Forshew, Tim;
    • Gale, Davina;
    • Liu, Wei;
    • Morris, James;
    • Marass, Francesco;
    • Eisen, Tim;
    • Chin, Tan Min;
    • Rosenfeld, Nitzan
    Publication type:
    Article
    6